AN2 Therapeutics Inc. (NASDAQ:ANTX) shares were down during Wednesday’s premarket session in a volatile session. At the open, the stock recovered the losses.AN2 Therapeutics’ $40 Million FinancingThe company surged over 90% on Tuesday following a recent announcement regarding a $40 million private placement financing.The financing includes the sale of around 8.2 million shares at $2.85 each, along with pre-funded warrants for up to 5.8 million additional shares at a nearly identical purchase price.Focuses O ...